The RADIATE network is composed of seven full partners from different European academic institutions.
These academic institutions host our Early Stage Researchers (ESRs).
The network also consists of seven associated partners, including academic and industrial organisations.
Moreover RADIATE has an external expert advisory board with three members.
We aim to enhance clinical and basic research in Oxford with the ultimate goal of increasing cancer cure rates.
The focus of the research group is in the area of molecular cell biology and experimental radiooncology.
Our goal is to understand the basic mechanisms of treatment failure in cancer and to apply this knowledge to improve outcomes.
The Radiology section of OncoRay is concerned with the investigation of resistance mechanisms and the effect of radiochemotherapy.
Hypoxia is a cancer hallmark that imposes a selection pressure on tumor cells.
We have developed an original method using small molecule compounds to inhibit all DNA repair pathways.
The major focus of our translational research activities is ‘Combined Treatment Modality in Radiation Oncology’.
Part funded from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant
Department of Oncology
Old Road Campus Research Building
Oxford, OX3 7DQ